Safety and Efficacy of HFA-134a Beclomethasone Dipropionate Extra-Fine Aerosol over Six Months

OBJECTIVE: To compare the systemic safety and efficacy of hydrofluoroalkane beclomethasone dipropionate (HFA-BDP) extra-fine aerosol 800 µg/day with chlorofluorocarbon (CFC)-BDP 1500 µg/day.

Saved in:
Bibliographic Details
Main Authors: Louis-Philippe Boulet, André Cartier, Pierre Ernst, Pierre Larivée, Michel Laviolette
Format: Article
Language:English
Published: Wiley 2004-01-01
Series:Canadian Respiratory Journal
Online Access:http://dx.doi.org/10.1155/2004/823084
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832561159828406272
author Louis-Philippe Boulet
André Cartier
Pierre Ernst
Pierre Larivée
Michel Laviolette
author_facet Louis-Philippe Boulet
André Cartier
Pierre Ernst
Pierre Larivée
Michel Laviolette
author_sort Louis-Philippe Boulet
collection DOAJ
description OBJECTIVE: To compare the systemic safety and efficacy of hydrofluoroalkane beclomethasone dipropionate (HFA-BDP) extra-fine aerosol 800 µg/day with chlorofluorocarbon (CFC)-BDP 1500 µg/day.
format Article
id doaj-art-909d3e2c7f9f40299b83ab7761b2170d
institution Kabale University
issn 1198-2241
language English
publishDate 2004-01-01
publisher Wiley
record_format Article
series Canadian Respiratory Journal
spelling doaj-art-909d3e2c7f9f40299b83ab7761b2170d2025-02-03T01:25:44ZengWileyCanadian Respiratory Journal1198-22412004-01-0111212313010.1155/2004/823084Safety and Efficacy of HFA-134a Beclomethasone Dipropionate Extra-Fine Aerosol over Six MonthsLouis-Philippe Boulet0André Cartier1Pierre Ernst2Pierre Larivée3Michel Laviolette4Institut universitaire de cardiologie et de pneumologie, l’Université Laval, Hôpital Laval, Sainte-Foy, Quebec, CanadaService de pneumologie, Hôpital du Sacré-Coeur, Montreal, Quebec, CanadaHôpital Général de Montréal, Montreal, Quebec, CanadaCentre hospitalier universitaire de Sherbrooke, Sherbrooke, Quebec, CanadaInstitut universitaire de cardiologie et de pneumologie, l’Université Laval, Hôpital Laval, Sainte-Foy, Quebec, CanadaOBJECTIVE: To compare the systemic safety and efficacy of hydrofluoroalkane beclomethasone dipropionate (HFA-BDP) extra-fine aerosol 800 µg/day with chlorofluorocarbon (CFC)-BDP 1500 µg/day.http://dx.doi.org/10.1155/2004/823084
spellingShingle Louis-Philippe Boulet
André Cartier
Pierre Ernst
Pierre Larivée
Michel Laviolette
Safety and Efficacy of HFA-134a Beclomethasone Dipropionate Extra-Fine Aerosol over Six Months
Canadian Respiratory Journal
title Safety and Efficacy of HFA-134a Beclomethasone Dipropionate Extra-Fine Aerosol over Six Months
title_full Safety and Efficacy of HFA-134a Beclomethasone Dipropionate Extra-Fine Aerosol over Six Months
title_fullStr Safety and Efficacy of HFA-134a Beclomethasone Dipropionate Extra-Fine Aerosol over Six Months
title_full_unstemmed Safety and Efficacy of HFA-134a Beclomethasone Dipropionate Extra-Fine Aerosol over Six Months
title_short Safety and Efficacy of HFA-134a Beclomethasone Dipropionate Extra-Fine Aerosol over Six Months
title_sort safety and efficacy of hfa 134a beclomethasone dipropionate extra fine aerosol over six months
url http://dx.doi.org/10.1155/2004/823084
work_keys_str_mv AT louisphilippeboulet safetyandefficacyofhfa134abeclomethasonedipropionateextrafineaerosoloversixmonths
AT andrecartier safetyandefficacyofhfa134abeclomethasonedipropionateextrafineaerosoloversixmonths
AT pierreernst safetyandefficacyofhfa134abeclomethasonedipropionateextrafineaerosoloversixmonths
AT pierrelarivee safetyandefficacyofhfa134abeclomethasonedipropionateextrafineaerosoloversixmonths
AT michellaviolette safetyandefficacyofhfa134abeclomethasonedipropionateextrafineaerosoloversixmonths